CD80 and neoplasm: Flow cytometry of the tumor immune microenvironment revealed a decreased expression of the M2 marker arginase in tumor-associated macrophages but an unchanged expression of M1 markers INOS, CD80 and MHC I (Figure 5D,E, Supplementary Figure S4) and an increase in M1 marker CD64 (Supplementary Figure S4).